FDA Inspection 1095580 — Livzon New North River Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon New North River Pharmaceutical Co., Ltd. on May 23, 2019 in Qingyuan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingyuan (China)